Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/688091 stock hub

SHA/688091 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688091is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688091

In the news

Latest news · SHA/688091

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E183.9

P25 23.5P50 41.3P75 83.2

ROE4.7

P25 -0.9P50 4.1P75 8.8

ROIC5.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688091 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

CNY

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	415
Employees Change	96%
Employees Change Percent	30.09
Enterprise value	CNY 12.1B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000050F4
Last refreshed	2026-05-10
Market cap	CNY 12.4B
Price	CNY 60.6
Price currency	CNY
Rev Per Employee	867,206.87x
Sector	Healthcare
Sic	2834
Symbol	sha/688091
Website	https://www.yizhongpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.55%
EV Earnings	177x
EV/EBIT	198.68x
EV/Sales	37.07x
P/B ratio	8.59x
P/E ratio	183.88x
P/S ratio	38.28x
PE Ratio3 Y	302.58x
PE Ratio5 Y	248.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.66%
Gross margin	100.48%
Gross Profit	CNY 326.8M
Gross Profit Growth	113.51%
Gross Profit Growth Q	16.74%
Gross Profit Growth3 Y	6.27%
Net Income	CNY 68.1M
Net Income Growth Q	28.07%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	-25.86%
Pretax Margin	19.2%
Profit Margin	20.94%
Profit Per Employee	CNY 181,636
Profitable Years	4
ROA	2.52
ROCE	4.1
ROE	4.74
Roe5y	5.49
ROIC	5.9
Roic5y	18.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	39.34%
Cagr3y	1.4%
EPS Growth Q	28.57
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	-25.87
Revenue Growth	84.92x
Revenue Growth Q	11.44x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	3.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.22
Assets	CNY 1.5B
Cash	CNY 418.2M
Current Assets	CNY 640.1M
Current Liabilities	CNY 67.5M
Debt	CNY 25M
Debt Equity	CNY 0.02
Equity	CNY 1.4B
Liabilities	CNY 97.5M
Long Term Assets	CNY 905.8M
Long Term Liabilities	CNY 30M
Net Cash	CNY 393.2M
Net Cash By Market Cap	CNY 3.16
Net Cash Growth	-37.9%
Net Debt Equity	CNY -0.27
Tangible Book Value	CNY 1.4B
Tangible Book Value Per Share	CNY 7.03
WACC	1.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.48
Net Working Capital	CNY 154.4M
Quick ratio	8.21
Working Capital	CNY 572.6M
Working Capital Turnover	CNY 0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	14.82%
Dividend per share	CNY 0
Last Dividend	CNY 0.31

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	39.31%
200-day SMA	57
3Y total return	4.24%
50-day SMA	54.49
50-day SMA vs 200-day SMA	50under200
All Time High	102.3
All Time High Change	-40.74%
All Time High Date	2022-06-10
All Time Low	19.76
All Time Low Change	206.76%
All Time Low Date	2021-09-22
ATR	2.91
Beta	-0.43
Beta1y	-0.23
Beta2y	-0.17
Ch YTD	28.94
High	61.86
High52	83.6
High52 Date	2025-08-18
High52ch	-27.51%
Low	59
Low52	40.09
Low52 Date	2025-05-21
Low52ch	51.16%
Ma50ch	11.21%
Price vs 200-day SMA	6.31%
RSI	63.14
RSI Monthly	58.7
RSI Weekly	57.46
Sharpe ratio	0.7x
Sortino ratio	1.34
Total Return	14.82%
Tr YTD	28.94
Tr1m	3.93%
Tr1w	6.32%
Tr3m	20.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 60.7M
Operating Income Growth Q	-1.43
Operating Income Growth3 Y	-25
Operating margin	18.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	103,010,387%
Shares Insiders	29.44%
Shares Institutions	7.42%
Shares Out	205,429,333
Shares Qo Q	-8.08%
Shares Yo Y	-14.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,295,486.55x
Bv Per Share	7.18
Ch1m	3.93
Ch1w	6.32
Ch1y	39.31
Ch3m	20.79
Ch3y	3.39
Ch6m	16.49
Change	0.02%
Change From Open	-2.04
Close	60.59
Days Gap	2.1
Dollar Volume	348,345,707.4
Earnings Date	2026-04-28
EBIT	CNY 60.7M
EPS	CNY 0.33
F Score	4
Fiscal Year End	December
Founded	2,009
Graham Number	7.29438
Graham Upside	-87.96
Income Tax	CNY -5.7M
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2024-05-17
Last Split Type	Forward
Lynch Fair Value	CNY 1.65
Lynch Upside	-97.28
Ma150	53.26
Ma150ch	13.79%
Ma20	55.98
Ma20ch	8.25%
Open	61.86
Position In Range	55.94
Ppne	276,796,307
Price Date	2026-05-08
Ptbv Ratio	8.78
Relative Volume	1.1x
Revenue	325,202,578x
Tax By Revenue	-1.75x
Tr6m	16.49%
Volume	5,748,279

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHA/688091 pay a dividend?

Capital-return profile for this ticker.

Performance

SHA/688091 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688091?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.4%

Share of float held by funds and institutions

Insider ownership

+29.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-14.8%

Negative means the company is buying back shares.

Technical

SHA/688091 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.1

Neutral momentum band

Price vs 200-day MA

+6.3%

50/200-day relationship not available

Beta (5Y)

-0.43

Less volatile than the market

Sharpe ratio

0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688091

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688091 stock rating?

sha/688091 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688091 analysis?

The full report lives at /stocks/sha/688091/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688091?

The latest report frames sha/688091 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688091 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.